| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A dedication to Alfred L. Goldberg
|
Attaix, Didier
|
|
2013
|
45 |
10 |
p. 2120-
1 p.
|
article
|
| 2 |
β2-Adrenergic agonists and the treatment of skeletal muscle wasting disorders
|
Joassard, Olivier R.
|
|
2013
|
45 |
10 |
p. 2309-2321
13 p.
|
article
|
| 3 |
Calcineurin: A poorly understood regulator of muscle mass
|
Hudson, Matthew B.
|
|
2013
|
45 |
10 |
p. 2173-2178
6 p.
|
article
|
| 4 |
Clinical outcomes related to muscle mass in humans with cancer and catabolic illnesses
|
Baracos, Vickie
|
|
2013
|
45 |
10 |
p. 2302-2308
7 p.
|
article
|
| 5 |
Control of food intake and muscle wasting in cachexia
|
Amitani, Marie
|
|
2013
|
45 |
10 |
p. 2179-2185
7 p.
|
article
|
| 6 |
Deciphering the ubiquitin proteome: Limits and advantages of high throughput global affinity purification-mass spectrometry approaches
|
Polge, Cécile
|
|
2013
|
45 |
10 |
p. 2136-2146
11 p.
|
article
|
| 7 |
Deubiquitinases in skeletal muscle atrophy
|
Wing, Simon S.
|
|
2013
|
45 |
10 |
p. 2130-2135
6 p.
|
article
|
| 8 |
Disuse-induced muscle wasting
|
Bodine, Sue C.
|
|
2013
|
45 |
10 |
p. 2200-2208
9 p.
|
article
|
| 9 |
Editorial Board
|
|
|
2013
|
45 |
10 |
p. CO2-
1 p.
|
article
|
| 10 |
eIF3f: A central regulator of the antagonism atrophy/hypertrophy in skeletal muscle
|
Sanchez, Anthony M.J.
|
|
2013
|
45 |
10 |
p. 2158-2162
5 p.
|
article
|
| 11 |
Glucocorticoid-induced skeletal muscle atrophy
|
Schakman, O.
|
|
2013
|
45 |
10 |
p. 2163-2172
10 p.
|
article
|
| 12 |
Mitochondrial dysfunction and sarcopenia of aging: From signaling pathways to clinical trials
|
Marzetti, Emanuele
|
|
2013
|
45 |
10 |
p. 2288-2301
14 p.
|
article
|
| 13 |
Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: Potential therapeutic targets for cardiac cachexia
|
Yoshida, Tadashi
|
|
2013
|
45 |
10 |
p. 2322-2332
11 p.
|
article
|
| 14 |
Molecular mechanisms of muscle atrophy in myotonic dystrophies
|
Timchenko, Lubov
|
|
2013
|
45 |
10 |
p. 2280-2287
8 p.
|
article
|
| 15 |
Muscle atrophy: From molecular pathways to clinical therapy
|
Kargul, Joanna
|
|
2013
|
45 |
10 |
p. 2119-
1 p.
|
article
|
| 16 |
Muscle type and fiber type specificity in muscle wasting
|
Ciciliot, Stefano
|
|
2013
|
45 |
10 |
p. 2191-2199
9 p.
|
article
|
| 17 |
Muscle wasting from kidney failure—A model for catabolic conditions
|
Wang, Xiaonan H.
|
|
2013
|
45 |
10 |
p. 2230-2238
9 p.
|
article
|
| 18 |
Muscle wasting in cancer
|
Johns, N.
|
|
2013
|
45 |
10 |
p. 2215-2229
15 p.
|
article
|
| 19 |
Muscle wasting in heart failure: An overview
|
von Haehling, Stephan
|
|
2013
|
45 |
10 |
p. 2257-2265
9 p.
|
article
|
| 20 |
Muscle wasting: The gut microbiota as a new therapeutic target?
|
Bindels, Laure B.
|
|
2013
|
45 |
10 |
p. 2186-2190
5 p.
|
article
|
| 21 |
Myostatin/activin pathway antagonism: Molecular basis and therapeutic potential
|
Han, H.Q.
|
|
2013
|
45 |
10 |
p. 2333-2347
15 p.
|
article
|
| 22 |
Protein breakdown in muscle wasting: Role of autophagy-lysosome and ubiquitin-proteasome
|
Sandri, Marco
|
|
2013
|
45 |
10 |
p. 2121-2129
9 p.
|
article
|
| 23 |
Regulation of muscle protein synthesis and the effects of catabolic states
|
Gordon, Bradley S.
|
|
2013
|
45 |
10 |
p. 2147-2157
11 p.
|
article
|
| 24 |
Resistance exercise and the mechanisms of muscle mass regulation in humans: Acute effects on muscle protein turnover and the gaps in our understanding of chronic resistance exercise training adaptation
|
Murton, A.J.
|
|
2013
|
45 |
10 |
p. 2209-2214
6 p.
|
article
|
| 25 |
The regulation of muscle protein turnover in diabetes
|
Workeneh, Biruh
|
|
2013
|
45 |
10 |
p. 2239-2244
6 p.
|
article
|
| 26 |
Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease
|
Langen, R.C.J.
|
|
2013
|
45 |
10 |
p. 2245-2256
12 p.
|
article
|
| 27 |
Wasting mechanisms in muscular dystrophy
|
Shin, Jonghyun
|
|
2013
|
45 |
10 |
p. 2266-2279
14 p.
|
article
|
Journal description